Variation in the purinergic P2RX7 receptor gene and schizophrenia

Schizophrenia Research

Volumn 104, Issue 1-3, 2008, Pages 146-152

  Hansen, Thomas ^a,d   Jakobsen, Klaus D ^a,d   Fenger, Mogens ^a   Nielsen, Jimmi ^b   Krane, Karoline ^a,c   Fink Jensen, Anders ^c   Lublin, Henrik ^a   Ullum, Henrik ^a   Timm, Sally ^a   Wang, August G ^a   Jørgensen, Niklas Rye ^a   Werge, Thomas ^a  

^a Mental Health Services CPH   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

P2XR7; Purinergic receptor; Register data; Treatment resistance

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PURINERGIC P2X7 RECEPTOR GENE; RECEPTOR GENE; SCHIZOPHRENIA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; DENMARK; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PURINERGIC P2; SCHIZOPHRENIA; YOUNG ADULT;

EID: 50249118162     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.05.026     Document Type: Article

References (48)

1. Bailer U., Leisch F., Meszaros K., Lenzinger E., Willinger U., Strobl R., Gebhardt C., Gerhard E., Fuchs K., Sieghart W., Kasper S., Hornik K., and Aschauer H.N. Genome scan for susceptibility loci for schizophrenia. Neuropsychobiology 42 (2000) 175-182
2. Bailer U., Leisch F., Meszaros K., Lenzinger E., Willinger U., Strobl R., Heiden A., Gebhardt C., Doge E., Fuchs K., Sieghart W., Kasper S., Hornik K., and Aschauer H.N. Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol. Psychiatry 52 (2002) 40-52
3. Barden N., Harvey M., Gagne B., Shink E., Tremblay M., Raymond C., Labbe M., Villeneuve A., Rochette D., Bordeleau L., Stadler H., Holsboer F., and Muller-Myhsok B. Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141 (2006) 374-382
4. Brzustowicz L.M., Hodgkinson K.A., Chow E.W., Honer W.G., and Bassett A.S. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288 (2000) 678-682
5. Cabrini G., Falzoni S., Forchap S.L., Pellegatti P., Balboni A., Agostini P., Cuneo A., Castoldi G., Baricordi O.R., and Di V.F. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J. Immunol. 175 (2005) 82-89
6. DeLisi L.E., Shaw S.H., Crow T.J., Shields G., Smith A.B., Larach V.W., Wellman N., Loftus J., Nanthakumar B., Razi K., Stewart J., Comazzi M., Vita A., Heffner T., and Sherrington R. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am. J. Psychiatry 159 (2002) 803-812
7. Deuchars S.A., Atkinson L., Brooke R.E., Musa H., Milligan C.J., Batten T.F., Buckley N.J., Parson S.H., and Deuchars J. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J. Neurosci. 21 (2001) 7143-7152
8. Dracheva S., Elhakem S.L., McGurk S.R., Davis K.L., and Haroutunian V. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J. Neurosci. Res. 76 (2004) 581-592
9. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25 (2003) 115-121
10. Ferrari D., Chiozzi P., Falzoni S., Hanau S., and Di V.F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185 (1997) 579-582
11. Gu B.J., Sluyter R., Skarratt K.K., Shemon A.N., Dao-Ung L.P., Fuller S.J., Barden J.A., Clarke A.L., Petrou S., and Wiley J.S. An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J. Biol. Chem. 279 (2004) 31287-31295
12. Hashimoto T., and Lewis D.A. BDNF Val66Met polymorphism and GAD67 mRNA expression in the prefrontal cortex of subjects with schizophrenia. Am. J. Psychiatry 163 (2006) 534-537
13. Hervas C., Perez-Sen R., and Miras-Portugal M.T. Presence of diverse functional P2X receptors in rat cerebellar synaptic terminals. Biochem. Pharmacol. 70 (2005) 770-785
14. Hoebertz A., Townsend-Nicholson A., Glass R., Burnstock G., and Arnett T.R. Expression of P2 receptors in bone and cultured bone cells. Bone 27 (2000) 503-510
15. Illes P., and Ribeiro J.A. Neuronal P2 receptors of the central nervous system. Curr. Top. Med. Chem. 4 (2004) 831-838
16. Jakobsen K.D., Frederiksen J.N., Hansen T., Jansson L.B., Parnas J., and Werge T. Reliability of clinical ICD-10 schizophrenia diagnoses. Nord. J. Psychiatry 59 (2005) 209-212
17. Jakobsen K.D., Frederiksen J.N., Parnas J., and Werge T. Diagnostic agreement of schizophrenia spectrum disorders among chronic patients with functional psychoses. Psychopathology 39 (2006) 269-276
18. Jakobsen K.D., Hansen T., and Werge T. Diagnostic stability among chronic patients with functional psychoses: an epidemiological and clinical study. BMC Psychiatry 7 (2007) 41
19. Jorgensen N.R., Henriksen Z., Sorensen O.H., Eriksen E.F., Civitelli R., and Steinberg T.H. Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors. J. Biol. Chem. 277 (2002) 7574-7580
20. Juranyi Z., Sperlagh B., and Vizi E.S. Involvement of P2 purinoceptors and the nitric oxide pathway in [3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res. 823 (1999) 183-190
21. Lewis D.A., and Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch. Neurol. 63 (2006) 1372-1376
22. Lewis D.A., Pierri J.N., Volk D.W., Melchitzky D.S., and Woo T.U. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol. Psychiatry 46 (1999) 616-626
23. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., Williams N.M., Schwab S.G., Pulver A.E., Faraone S.V., Brzustowicz L.M., Kaufmann C.A., Garver D.L., Gurling H.M., Lindholm E., Coon H., Moises H.W., Byerley W., Shaw S.H., Mesen A., Sherrington R., O'Neill F.A., Walsh D., Kendler K.S., Ekelund J., Paunio T., Lonnqvist J., Peltonen L., O'Donovan M.C., Owen M.J., Wildenauer D.B., Maier W., Nestadt G., Blouin J.L., Antonarakis S.E., Mowry B.J., Silverman J.M., Crowe R.R., Cloninger C.R., Tsuang M.T., Malaspina D., Harkavy-Friedman J.M., Svrakic D.M., Bassett A.S., Holcomb J., Kalsi G., McQuillin A., Brynjolfson J., Sigmundsson T., Petursson H., Jazin E., Zoega T., and Helgason T. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am. J. Hum. Genet. 73 (2003) 34-48
24. Liu Y.L., Fann C.S., Liu C.M., Chang C.C., Wu J.Y., Hung S.I., Liu S.K., Hsieh M.H., Hwang T.J., Chan H.Y., Chen J.J., Faraone S.V., Tsuang M.T., Chen W.J., and Hwu H.G. No association of G72 and D-amino acid oxidase genes with schizophrenia. Schizophr. Res. 87 (2006) 15-20
25. McLarnon J.G. Purinergic mediated changes in Ca2+ mobilization and functional responses in microglia: effects of low levels of ATP. J. Neurosci. Res. 81 (2005) 349-356
26. Miras-Portugal M.T., az-Hernandez M., Giraldez L., Hervas C., Gomez-Villafuertes R., Sen R.P., Gualix J., and Pintor J. P2X7 receptors in rat brain: presence in synaptic terminals and granule cells. Neurochem. Res. 28 (2003) 1597-1605
27. Moller H.J. Bipolar disorder and schizophrenia: distinct illnesses or a continuum?. J. Clin. Psychiatry 64 Suppl 6 (2003) 23-27
28. Naemsch L.N., Dixon S.J., and Sims S.M. Activity-dependent development of P2X7 current and Ca2+ entry in rabbit osteoclasts. J. Biol. Chem. 276 (2001) 39107-39114
29. Ohlendorff S.D., Tofteng C.L., Jensen J.E., Petersen S., Civitelli R., Fenger M., Abrahamsen B., Hermann A.P., Eiken P., and Jrgensen N.R. Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment. Pharmacogenet. Genomics 17 (2007) 555-567
30. Papp L., Vizi E.S., and Sperlagh B. Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-/- mice. Neuroreport 15 (2004) 2387-2391
31. Perlstein W.M., Carter C.S., Noll D.C., and Cohen J.D. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am. J. Psychiatry 158 (2001) 1105-1113
32. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
33. Reif A., Herterich S., Strobel A., Ehlis A.C., Saur D., Jacob C.P., Wienker T., Topner T., Fritzen S., Walter U., Schmitt A., Fallgatter A.J., and Lesch K.P. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol. Psychiatry 11 (2006) 286-300
34. Schleimer S.B., Hinton T., Dixon G., and Johnston G.A. GABA transporters GAT-1 and GAT-3 in the human dorsolateral prefrontal cortex in schizophrenia. Neuropsychobiology 50 (2004) 226-230
35. Shemon A.N., Sluyter R., Fernando S.L., Clarke A.L., Dao-Ung L.P., Skarratt K.K., Saunders B.M., Tan K.S., Gu B.J., Fuller S.J., Britton W.J., Petrou S., and Wiley J.S. A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J. Biol. Chem. 281 (2006) 2079-2086
36. Shink E., Harvey M., Tremblay M., Gagne B., Belleau P., Raymond C., Labbe M., Dube M.P., Lafreniere R.G., and Barden N. Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 135 (2005) 50-58
37. Shinkai T., Ohmori O., Hori H., and Nakamura J. Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol. Psychiatry 7 (2002) 560-563
38. Skarratt K.K., Fuller S.J., Sluyter R., Dao-Ung L.P., Gu B.J., and Wiley J.S. A 5' intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1-2% of the Caucasian population. FEBS Lett. 579 (2005) 2675-2678
39. Sluyter R., Shemon A.N., and Wiley J.S. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes. J. Immunol. 172 (2004) 3399-3405
40. Sperlagh B., Kofalvi A., Deuchars J., Atkinson L., Milligan C.J., Buckley N.J., and Vizi E.S. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J. Neurochem. 81 (2002) 1196-1211
41. Sperlagh B., Baranyi M., Hasko G., and Vizi E.S. Potent effect of interleukin-1 beta to evoke ATP and adenosine release from rat hippocampal slices. J. Neuroimmunol. 151 (2004) 33-39
42. Sperlagh B., Vizi E.S., Wirkner K., and Illes P. P2X7 receptors in the nervous system. Prog. Neurobiol. 78 (2006) 327-346
43. Steinberg T.H., and Silverstein S.C. Extracellular. J. Biol. Chem. 262 (1987) 3118-3122
44. Steinberg T.H., Newman A.S., Swanson J.A., and Silverstein S.C. J. Biol. Chem. 262 (1987) 8884-8888
45. Wilcox M.A., Faraone S.V., Su J., Van E.P., and Tsuang M.T. Genome scan of three quantitative traits in schizophrenia pedigrees. Biol. Psychiatry 52 (2002) 847-854
46. Wiley J.S., Dao-Ung L.P., Gu B.J., Sluyter R., Shemon A.N., Li C., Taper J., Gallo J., and Manoharan A. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 359 (2002) 1114-1119
47. Wiley J.S., Dao-Ung L.P., Li C., Shemon A.N., Gu B.J., Smart M.L., Fuller S.J., Barden J.A., Petrou S., and Sluyter R. An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. J. Biol. Chem. 278 (2003) 17108-17113
48. Wood L.S., Pickering E.H., and Dechairo B.M. Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biol. Psychiatry 61 (2007) 1195-1199